Taylor Stone, PA
Medical · Terre Haute, INNPI 1790175602
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,546 of the $5,190 with a category attached, or 87.6%. It is spread thinly across 24 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations.
Across 182 payments — averaging $28.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$927
- Intuitive Surgical$624
- AstraZeneca$532
- Novartis$508
- E.r. Squibb & Sons, L.L.C.$424
- Boehringer Ingelheim$340
- plus $2K from 18 others
What the payments were for
- Travel & lodging$62412%
- Food & beverage$4,54688%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 46 | $927 |
| Intuitive Surgical | 5 | $624 |
| AstraZeneca | 11 | $532 |
| Novartis | 29 | $508 |
| E.r. Squibb & Sons, L.L.C. | 16 | $424 |
| Boehringer Ingelheim | 8 | $340 |
| Boston Scientific | 9 | $289 |
| Johnson & Johnson | 5 | $250 |
| Pfizer | 9 | $237 |
| Kestra Medical Technology Services, Inc. | 7 | $145 |
| Merck | 8 | $135 |
| Endologix LLC | 1 | $122 |
| Sanofi-aventis U.S. LLC | 3 | $112 |
| Novo Nordisk | 6 | $110 |
| Actelion Pharmaceuticals US, Inc. | 1 | $88 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $67 |
| Biotronik Inc. | 1 | $65 |
| EMD Serono, Inc. | 4 | $61 |
| Scpharmaceuticals Inc. | 2 | $34 |
| Lexicon Pharmaceuticals, Inc. | 2 | $33 |
| Bayer | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Cvrx, Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$580
- Repatha$349
- FARXIGA$249
- JARDIANCE$240
- XARELTO$200
- ENDOCROSS Device$122
- Torus Stent Graft System$122
- CAMZYOS$121
How this compares
$5,190 in reported general payments places this provider in the 85th percentile of 273 medical providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 130 | $101,488 |
| Repatha SureclickEvolocumab | 115 | $88,968 |
| EntrestoSacubitril/Valsartan | 97 | $87,458 |
| XareltoRivaroxaban | 56 | $48,769 |
| JardianceEmpagliflozin | 41 | $39,598 |
| Repatha SyringeEvolocumab | 17 | $9,438 |
| Atorvastatin Calcium | 307 | $2,604 |
| Ranolazine ErRanolazine | 34 | $2,567 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 275 | $2,498 |
| Carvedilol | 370 | $2,101 |
| Losartan Potassium | 227 | $1,455 |
| Potassium Chloride | 27 | $1,318 |
| Amlodipine Besylate | 217 | $1,301 |
| ClopidogrelClopidogrel Bisulfate | 160 | $1,084 |
| Spironolactone | 129 | $1,059 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $237 | $101,488130 claims |
| NovartisEntresto | $508 | $87,45897 claims |
| Johnson & JohnsonXarelto | $250 | $48,76956 claims |
| Boehringer IngelheimJardiance | $340 | $39,59841 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 273 medical providers in Indiana.
Other medical in Terre Haute
- Briseida Oceguera PerezTerre Haute$5K
- Christopher SchmidtTerre Haute$4K
- Jacklyn SloverTerre Haute$2K
- Meggie BeckleyIndianapolis$125K
- Jennifer ConnerIndianapolis$98K
- Brandon BoydCarmel$46K
- Karey DavisNew Castle$45K
- Sheryl NewCarmel$39K
- Lindsey GradyValparaiso$39K
- Jennifer IrwinIndianapolis$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.